Company Filing History:
2 out of 832,912 Years Active: 2003
Title: Kenneth R Korzekwa: Innovator in Pharmaceutical Design
Introduction
Kenneth R Korzekwa is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceutical design, particularly in understanding drug metabolism and toxicology. With a total of 2 patents, his work has paved the way for novel approaches in drug development.
Latest Patents
Kenneth's latest patents include innovative methodologies for utilizing computational and experimental data to model organic compound reactivity in cytochrome P450 mediated reactions. This invention focuses on the design of new pharmaceuticals and predicting their metabolism and toxicological profiles. By leveraging computational data, Kenneth aims to enhance the understanding of drug metabolism, especially concerning monooxygenase enzymes involved in this process. His second patent addresses the identification of reactive sites on substrate molecules, determining the relative rates of their metabolism by CYP enzymes. This information is crucial for improving the ADME/PK properties of drugs.
Career Highlights
Throughout his career, Kenneth has demonstrated a commitment to advancing pharmaceutical sciences. His innovative approaches have garnered attention in the industry, contributing to the development of safer and more effective drugs. His work is characterized by a blend of computational analysis and experimental validation, ensuring that his inventions are grounded in scientific rigor.
Collaborations
Kenneth has collaborated with esteemed colleagues such as Jeffrey P Jones and Lee Ann Higgins. These partnerships have enriched his research and expanded the impact of his inventions in the pharmaceutical field.
Conclusion
Kenneth R Korzekwa stands out as a pioneering inventor in the realm of pharmaceutical design. His contributions through innovative patents have significantly advanced the understanding of drug metabolism and toxicity. His work continues to influence the development of new pharmaceuticals, ensuring safer and more effective treatments for patients.